Format

Send to

Choose Destination
Bioorg Med Chem. 2013 Nov 15;21(22):6981-95. doi: 10.1016/j.bmc.2013.09.023. Epub 2013 Sep 18.

The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.

Author information

1
Institute of Drug Discovery and Development, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, PR China.

Abstract

A novel class of podophyllotoxin derivatives have been designed and synthesized based on the synergistic antitumor effects of topoisomerase II and histone deacetylase inhibitors. Their inhibitory activities towards histone deacetylases and Topo II and their cytotoxicities in cancer cell lines were evaluated. The aromatic capping group connection, linker length and zinc-binding group were systematically varied and preliminary conclusions regarding structure-activity relationships are discussed. Among all of the synthesized hybrid compounds, compound 24 d showed the most potent HDAC inhibitory activity at a low nanomolar level and exhibited powerful antiproliferative activity towards HCT116 colon carcinoma cells at a low micromolar level. Further exploration of this series led to the discovery of potent dual inhibitor 32, which exhibited the strongest in vitro cytotoxic activity.

KEYWORDS:

Cancer; HDAC; Hybrid; Podophyllotoxin; Synergistic effect; Topoisomerase II

PMID:
24095018
DOI:
10.1016/j.bmc.2013.09.023
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center